Research programme: cyclo-oxygenase-2 inhibitors - FAES

Drug Profile

Research programme: cyclo-oxygenase-2 inhibitors - FAES

Alternative Names: COX-2 inhibitors research programme - FAES; Cyclo-oxygenase-2 inhibitors research programme - FAES; Research programme: COX-2 inhibitors - FAES

Latest Information Update: 23 Mar 2009

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator FAES Farma
  • Class
  • Mechanism of Action Cyclo-oxygenase 2 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Inflammation

Most Recent Events

  • 06 Sep 2004 Data presented at the XVIIIth International Symposium on Medicinal Chemistry (ISMC-2004) have been added to the Inflammation pharmacodynamics section
  • 14 Sep 2001 This programme is still in active development
  • 22 Sep 1999 Preclinical development for Inflammation in Spain (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top